DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial

Autor: Sundar, Raghav, Ng, Alvin, Zouridis, Hermioni, Padmanabhan, Nisha, Sheng, Taotao, Zhang, Shenli, Lee, Ming Hui, Ooi, Wen Fong, Qamra, Aditi, Inam, Imran, Hewitt, Lindsay C., So, Jimmy Bok-Yan, Koh, Vivien, Nankivell, Matthew G., Langley, Ruth E., Allum, William H., Cunningham, David, Rozen, Steven G., Yong, Wei Peng, Grabsch, Heike I., Tan, Patrick
Zdroj: In European Journal of Cancer December 2019 123:48-57
Databáze: ScienceDirect
Externí odkaz: